On August 04, 2022, Teva Pharmaceutical Industries Limited (NYSE: TEVA) opened at $10.01, higher 1.50% from the last session. During the day, the shares moved up to $10.155 and dropped to $9.98 before settling in for the closing price of $9.97. Price fluctuations for TEVA have ranged from $6.78 to $10.50 over the past 52 weeks.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -6.20%. Company’s average yearly earnings per share was noted 110.30% at the time writing. With a float of $1.10 billion, this company’s outstanding shares have now reached $1.11 billion.
The extent of productivity of a business whose workforce counts for 34713 workers is very important to gauge. In terms of profitability, gross margin is +47.10, operating margin of +19.36, and the pretax margin is +4.15.
Teva Pharmaceutical Industries Limited (TEVA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Teva Pharmaceutical Industries Limited is 1.50%, while institutional ownership is 46.10%. The most recent insider transaction that took place on Jul 28, was worth 525,590. In this transaction Exec. VP Chief Legal Officer of this company sold 58,163 shares at a rate of $9.04, taking the stock ownership to the 2,974 shares. Before that another transaction happened on May 17, when Company’s Executive VP, Global R&D sold 130,000 for $8.22, making the entire transaction worth $1,068,067. This insider now owns 1,387 shares in total.
Teva Pharmaceutical Industries Limited (TEVA) Latest Financial update
If we go through the results of last quarter, which was made public on 3/30/2022, the company posted $0.55 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at $0.56) by -$0.01. This company achieved a net margin of +2.63 while generating a return on equity of 4.20. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 110.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.00% during the next five years compared to 39.70% growth over the previous five years of trading.
Teva Pharmaceutical Industries Limited (NYSE: TEVA) Trading Performance Indicators
Check out the current performance indicators for Teva Pharmaceutical Industries Limited (TEVA). In the past quarter, the stock posted a quick ratio of 0.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.72. Likewise, its price to free cash flow for the trailing twelve months is 23.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.95, a number that is poised to hit 0.62 in the next quarter and is forecasted to reach 2.57 in one year’s time.
Technical Analysis of Teva Pharmaceutical Industries Limited (TEVA)
The latest stats from [Teva Pharmaceutical Industries Limited, TEVA] show that its last 5-days average volume of 20.0 million was superior to 10.51 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 97.69%. Additionally, its Average True Range was 0.41.
During the past 100 days, Teva Pharmaceutical Industries Limited’s (TEVA) raw stochastic average was set at 89.79%, which indicates a significant decrease from 98.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 101.94% in the past 14 days, which was higher than the 61.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.17, while its 200-day Moving Average is $8.54. Now, the first resistance to watch is $10.19. This is followed by the second major resistance level at $10.26. The third major resistance level sits at $10.36. If the price goes on to break the first support level at $10.01, it is likely to go to the next support level at $9.91. The third support level lies at $9.84 if the price breaches the second support level.
Teva Pharmaceutical Industries Limited (NYSE: TEVA) Key Stats
There are currently 1,103,330K shares outstanding in the company with a market cap of 11.17 billion. Presently, the company’s annual sales total 15,878 M according to its annual income of 417,000 K. Last quarter, the company’s sales amounted to 3,786 M and its income totaled -232,000 K.